207 related articles for article (PubMed ID: 11034115)
1. Potential involvement of mt1 receptor and attenuated sex steroid-induced calcium influx in the direct anti-proliferative action of melatonin on androgen-responsive LNCaP human prostate cancer cells.
Xi SC; Tam PC; Brown GM; Pang SF; Shiu SY
J Pineal Res; 2000 Oct; 29(3):172-83. PubMed ID: 11034115
[TBL] [Abstract][Full Text] [Related]
2. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
Siu SW; Lau KW; Tam PC; Shiu SY
Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of androgen-sensitive LNCaP prostate cancer growth in vivo by melatonin: association of antiproliferative action of the pineal hormone with mt1 receptor protein expression.
Xi SC; Siu SW; Fong SW; Shiu SY
Prostate; 2001 Jan; 46(1):52-61. PubMed ID: 11170132
[TBL] [Abstract][Full Text] [Related]
4. Hormonal interactions in human prostate tumor LNCaP cells.
Lupowitz Z; Zisapel N
J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):83-8. PubMed ID: 10215041
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative action of melatonin on human prostate cancer LNCaP cells.
Moretti RM; Marelli MM; Maggi R; Dondi D; Motta M; Limonta P
Oncol Rep; 2000; 7(2):347-51. PubMed ID: 10671684
[TBL] [Abstract][Full Text] [Related]
6. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
7. Interplay between sex steroids and melatonin in regulation of human benign prostate epithelial cell growth.
Gilad E; Matzkin H; Zisapel N
J Clin Endocrinol Metab; 1997 Aug; 82(8):2535-41. PubMed ID: 9253330
[TBL] [Abstract][Full Text] [Related]
8. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
[TBL] [Abstract][Full Text] [Related]
9. Melatonin-induced inhibition of proliferation and G1/S cell cycle transition delay of human choriocarcinoma JAr cells: possible involvement of MT2 (MEL1B) receptor.
Shiu SY; Li L; Xu JN; Pang CS; Wong JT; Pang SF
J Pineal Res; 1999 Oct; 27(3):183-92. PubMed ID: 10535768
[TBL] [Abstract][Full Text] [Related]
10. LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids.
Esquenet M; Swinnen JV; Heyns W; Verhoeven G
J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):391-9. PubMed ID: 9449242
[TBL] [Abstract][Full Text] [Related]
11. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
Zhao XY; Ly LH; Peehl DM; Feldman D
Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T
Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968
[TBL] [Abstract][Full Text] [Related]
13. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
Fujinami K; Uemura H; Ishiguro H; Kubota Y
Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of malignant trophoblastic cell proliferation in vitro and in vivo by melatonin.
Shiu SY; Xi SC; Xu JN; Mei L; Pang SF; Yao KM; Wong JT
Life Sci; 2000 Sep; 67(17):2059-74. PubMed ID: 11057756
[TBL] [Abstract][Full Text] [Related]
15. Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines.
Kanishi Y; Kobayashi Y; Noda S; Ishizuka B; Saito K
J Pineal Res; 2000 May; 28(4):227-33. PubMed ID: 10831158
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
Arnold JT; Le H; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
[TBL] [Abstract][Full Text] [Related]
17. Mitogenic effect of nerve growth factor (NGF) in LNCaP prostate adenocarcinoma cells: role of the high- and low-affinity NGF receptors.
Sortino MA; Condorelli F; Vancheri C; Chiarenza A; Bernardini R; Consoli U; Canonico PL
Mol Endocrinol; 2000 Jan; 14(1):124-36. PubMed ID: 10628752
[TBL] [Abstract][Full Text] [Related]
18. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone.
Lee C; Sutkowski DM; Sensibar JA; Zelner D; Kim I; Amsel I; Shaw N; Prins GS; Kozlowski JM
Endocrinology; 1995 Feb; 136(2):796-803. PubMed ID: 7530653
[TBL] [Abstract][Full Text] [Related]
19. Melatonin receptors in PC3 human prostate tumor cells.
Gilad E; Laufer M; Matzkin H; Zisapel N
J Pineal Res; 1999 May; 26(4):211-20. PubMed ID: 10340723
[TBL] [Abstract][Full Text] [Related]
20. Changes of androgen receptor and insulin-like growth factor-1 in LNCaP prostate cancer cells treated with sex hormones and flutamide.
Tong da Y; Wen XQ; Jin Y; Liu ZW; Sun HY; Zhou FJ; Wu XY
Asian Pac J Cancer Prev; 2010; 11(6):1805-9. PubMed ID: 21338237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
